Novo Nordisk Forecast, price target & analysts
Novo Nordisk Target price 2025 - Analyst rating & recommendation
Novo Nordisk Classifications & Recommendation:
Novo Nordisk Price Target
| Target Price | kr408.00 |
| Price | kr331.55 |
| Potential |
23.06%
register free of charge
|
| Number of Estimates | 27 |
|
27 Analysts have issued a price target Novo Nordisk 2026 .
The average Novo Nordisk target price is kr408.00.
This is
23.06%
register free of charge
kr756.00
128.02%
register free of charge
kr272.70
17.75%
register free of charge
|
|
| A rating was issued by 32 analysts: 18 Analysts recommend Novo Nordisk to buy, 11 to hold and 3 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Novo Nordisk stock has an average upside potential 2026 of
23.06%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion kr | 290.40 | 311.47 |
| 25.03% | 7.25% | |
| EBITDA Margin | 48.98% | 48.83% |
| 6.29% | 0.31% | |
| Net Margin | 34.78% | 33.80% |
| 3.48% | 2.80% |
27 Analysts have issued a sales forecast Novo Nordisk 2025 . The average Novo Nordisk sales estimate is
This results in the following potential growth metrics:
24 Analysts have issued an Novo Nordisk EBITDA forecast 2025. The average Novo Nordisk EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
27 Novo Nordisk Analysts have issued a net profit forecast 2025. The average Novo Nordisk net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share kr | 22.63 | 23.71 |
| 21.54% | 4.77% | |
| P/E | 13.98 | |
| EV/Sales | 4.95 |
27 Analysts have issued a Novo Nordisk forecast for earnings per share. The average Novo Nordisk EPS is
This results in the following potential growth metrics and future valuations:
Current Novo Nordisk Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BERENBERG |
Locked
➜
Locked
|
Locked | Dec 09 2025 |
| NYKREDIT MARKETS |
Locked
➜
Locked
|
Locked | Dec 05 2025 |
| GUGGENHEIM SECURITIES LLC |
Locked
➜
Locked
|
Locked | Dec 03 2025 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Dec 01 2025 |
| ROTHSCHILD & CO REDBURN |
Locked
➜
Locked
|
Locked | Dec 01 2025 |
| JYSKE BANK |
Locked
➜
Locked
|
Locked | Dec 01 2025 |
| TD COWEN |
Locked
➜
Locked
|
Locked | Nov 25 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
BERENBERG:
Locked
➜
Locked
|
Dec 09 2025 |
|
Locked
NYKREDIT MARKETS:
Locked
➜
Locked
|
Dec 05 2025 |
|
Locked
GUGGENHEIM SECURITIES LLC:
Locked
➜
Locked
|
Dec 03 2025 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Dec 01 2025 |
|
Locked
ROTHSCHILD & CO REDBURN:
Locked
➜
Locked
|
Dec 01 2025 |
|
Locked
JYSKE BANK:
Locked
➜
Locked
|
Dec 01 2025 |
|
Locked
TD COWEN:
Locked
➜
Locked
|
Nov 25 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
